Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Human Insulin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Human Insulinmarket, defines the market attractiveness level of Recombinant Human Insulin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Human Insulin industry, describes the types of Recombinant Human Insulin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Human Insulin market and the development prospects and opportunities of Recombinant Human Insulin industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Human Insulin market in Chapter 13.
By Player:
Novo Nordisk
Wockhardt
Dongbro Pharmaceuticri
Gan & Lee
Dance Biopharm
Akron Biotech
United Laboratories
By Type:
by Recombinant DNA Technology Using Fermentation in Bacteria Way
by Recombinant DNA Technology Using Fermentation in Yeast Way
By End-User:
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Human Insulin Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Human Insulin Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Human Insulin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Human Insulin Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Human Insulin Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Human Insulin Consumption (2017-2022)
-
7.2 United States Recombinant Human Insulin Consumption (2017-2022)
-
7.3 Europe Recombinant Human Insulin Consumption (2017-2022)
-
7.4 China Recombinant Human Insulin Consumption (2017-2022)
-
7.5 Japan Recombinant Human Insulin Consumption (2017-2022)
-
7.6 India Recombinant Human Insulin Consumption (2017-2022)
-
7.7 South Korea Recombinant Human Insulin Consumption (2017-2022)
8 Region and Country-wise Recombinant Human Insulin Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Human Insulin Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Human Insulin Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Human Insulin Consumption Forecast (2022-2028)
-
8.4 China Recombinant Human Insulin Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Human Insulin Consumption Forecast (2022-2028)
-
8.6 India Recombinant Human Insulin Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Human Insulin Consumption Forecast (2022-2028)
9 Global Recombinant Human Insulin Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Human Insulin Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global by Recombinant DNA Technology Using Fermentation in Bacteria Way Consumption and Growth Rate (2017-2022)
-
9.1.2 Global by Recombinant DNA Technology Using Fermentation in Yeast Way Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Human Insulin Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Type 1 Diabetes Mellitus Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Type 2 Diabetes Mellitus Consumption and Growth Rate (2017-2022)
10 Global Recombinant Human Insulin Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Human Insulin Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global by Recombinant DNA Technology Using Fermentation in Bacteria Way Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global by Recombinant DNA Technology Using Fermentation in Yeast Way Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Human Insulin Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Type 1 Diabetes Mellitus Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Type 2 Diabetes Mellitus Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Human Insulin Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Human Insulin Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Human Insulin Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Human Insulin Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Human Insulin Market Competitive Analysis
-
14.1 Novo Nordisk
-
14.1.1 Novo Nordisk Company Details
-
14.1.2 Novo Nordisk Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novo Nordisk Recombinant Human Insulin Product and Service
-
14.2 Wockhardt
-
14.2.1 Wockhardt Company Details
-
14.2.2 Wockhardt Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Wockhardt Recombinant Human Insulin Product and Service
-
14.3 Dongbro Pharmaceuticri
-
14.3.1 Dongbro Pharmaceuticri Company Details
-
14.3.2 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Dongbro Pharmaceuticri Recombinant Human Insulin Product and Service
-
14.4 Gan & Lee
-
14.4.1 Gan & Lee Company Details
-
14.4.2 Gan & Lee Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gan & Lee Recombinant Human Insulin Product and Service
-
14.5 Dance Biopharm
-
14.5.1 Dance Biopharm Company Details
-
14.5.2 Dance Biopharm Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Dance Biopharm Recombinant Human Insulin Product and Service
-
14.6 Akron Biotech
-
14.6.1 Akron Biotech Company Details
-
14.6.2 Akron Biotech Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Akron Biotech Recombinant Human Insulin Product and Service
-
14.7 United Laboratories
-
14.7.1 United Laboratories Company Details
-
14.7.2 United Laboratories Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 United Laboratories Recombinant Human Insulin Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Human Insulin
-
Figure Recombinant Human Insulin Picture
-
Table Global Recombinant Human Insulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Human Insulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Human Insulin Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Human Insulin Consumption by Country (2017-2022)
-
Figure United States Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Human Insulin Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Recombinant DNA Technology Using Fermentation in Bacteria Way Consumption and Growth Rate (2017-2022)
-
Figure Global by Recombinant DNA Technology Using Fermentation in Yeast Way Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Diabetes Mellitus Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Mellitus Consumption and Growth Rate (2017-2022)
-
Figure Global by Recombinant DNA Technology Using Fermentation in Bacteria Way Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Recombinant DNA Technology Using Fermentation in Yeast Way Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Diabetes Mellitus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Diabetes Mellitus Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Human Insulin Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Human Insulin Export by Region (Top 5 Countries) (2017-2028)
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Recombinant Human Insulin Product and Service
-
Table Wockhardt (Foundation Year, Company Profile and etc.)
-
Table Wockhardt Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wockhardt Recombinant Human Insulin Product and Service
-
Table Dongbro Pharmaceuticri (Foundation Year, Company Profile and etc.)
-
Table Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongbro Pharmaceuticri Recombinant Human Insulin Product and Service
-
Table Gan & Lee (Foundation Year, Company Profile and etc.)
-
Table Gan & Lee Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gan & Lee Recombinant Human Insulin Product and Service
-
Table Dance Biopharm (Foundation Year, Company Profile and etc.)
-
Table Dance Biopharm Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dance Biopharm Recombinant Human Insulin Product and Service
-
Table Akron Biotech (Foundation Year, Company Profile and etc.)
-
Table Akron Biotech Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akron Biotech Recombinant Human Insulin Product and Service
-
Table United Laboratories (Foundation Year, Company Profile and etc.)
-
Table United Laboratories Recombinant Human Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table United Laboratories Recombinant Human Insulin Product and Service
-
